Cargando…

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa

BACKGROUND: Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. METHODS: We projected intensive care unit (ICU) needs and capacity fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Youngji, Jamieson, Lise, Edoka, Ijeoma, Long, Lawrence, Silal, Sheetal, Pulliam, Juliet R C, Moultrie, Harry, Sanne, Ian, Meyer-Rath, Gesine, Nichols, Brooke E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928624/ https://www.ncbi.nlm.nih.gov/pubmed/33732750 http://dx.doi.org/10.1093/ofid/ofab040

Ejemplares similares

The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity
por: Nichols, Brooke E, et al.
Publicado: (2020)

The role of modelling and analytics in South African COVID-19 planning and budgeting
por: Meyer-Rath, Gesine, et al.
Publicado: (2023)

Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa
por: Jamieson, Lise, et al.
Publicado: (2023)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
por: Silal, Sheetal Prakash, et al.
Publicado: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
por: Edoka, Ijeoma, et al.
Publicado: (2021)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
por: Benade, Mariet, et al.
Publicado: (2022)

What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations
por: Meyer‐Rath, Gesine, et al.
Publicado: (2023)

Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19
por: Lapadula, Giuseppe, et al.
Publicado: (2020)

Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa
por: Long, Lawrence C, et al.
Publicado: (2021)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Direct and Indirect Effects of the Coronavirus Disease 2019 Pandemic on Private Healthcare Utilization in South Africa, March 2020–September 2021
por: Perofsky, Amanda C, et al.
Publicado: (2022)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

Dexamethasone/remdesivir: Acute pancreatitis: case report
Publicado: (2022)

Estimating a cost-effectiveness threshold for health care decision-making in South Africa
por: Edoka, Ijeoma P, et al.
Publicado: (2020)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
por: Chiu, Calvin, et al.
Publicado: (2017)

Modeling the relationship between precipitation and malaria incidence in Mpumalanga, South Africa
por: Silal, Sheetal P
Publicado: (2012)

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
por: Silal, S P, et al.
Publicado: (2022)

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021)

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2019)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
por: Jamieson, Lise, et al.
Publicado: (2021)

Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves
por: Bingham, Jeremy, et al.
Publicado: (2022)

Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves
por: Bingham, Jeremy, et al.
Publicado: (2023)

Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
por: Kalligeros, Markos, et al.
Publicado: (2020)

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
por: Rajme-López, Sandra, et al.
Publicado: (2022)

Dexamethasone/propofol/remdesivir: Various toxicities: case report
Publicado: (2021)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Fewer COVID‐19 Neurological Complications with Dexamethasone and Remdesivir
por: Grundmann, Alexander, et al.
Publicado: (2022)

Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study
por: Koirala, Janak, et al.
Publicado: (2021)

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
por: Hedskog, Charlotte, et al.
Publicado: (2023)

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
por: Jittamala, Podjanee, et al.
Publicado: (2023)

Strengthening expertise for health technology assessment and priority-setting in Africa
por: Doherty, Jane E, et al.
Publicado: (2017)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
por: Mozaffari, Essy, et al.
Publicado: (2023)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96c3cv3rjbbeh866qu0ka7kv56